Fig. 1

Study design. (a) The scAAV vector genome was engineered to carry mono- or polycistronic artificial primary microRNA (apri-miR) sequences under control of a mouse transthyretin receptor (mTTR) promoter. ITR (inverted terminal repeats), int (intron) and TTS (transcription termination signal) are indicated schematically. (b) Engineered scAAV genomes were packaged into AAV2, AAV8 or Anc80L65 capsids. c-f. Upon administration, vectors mediate expression of pri-miRs (c) which are processed in several steps to generate pre-microRNA (pre-miR, d), and miR guides 5, 8 and 9 (e). Produced miRs then target all four HBV transcripts (green, purple and orange arrows shows target sites (f)) (created with Biorender)